LeonaBio (LONA) Payables (2019 - 2026)

LeonaBio (LONA) has 8 years of Payables data on file, last reported at $1.8 million in Q1 2026.

• On a quarterly basis, Payables rose 103.46% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 103.46% increase from a year earlier, with the FY2025 full-year figure at $4.6 million, up 1337.93% from the prior year.
• Payables for Q1 2026 stood at $1.8 million, down from $4.6 million in the prior quarter.
• Over the last five years, Payables for LONA reached as high as $4.6 million in Q4 2025 and fell as low as $129000.0 in Q4 2023.
• Historically, Payables has averaged $1.1 million across 5 years, with a median of $681000.0 in 2024.
• Across the five-year window, Payables sank 94.84% in 2023 and soared 1337.93% in 2025, its largest moves.
• Year by year, Payables stood at $2.5 million in 2022, then sank by 94.84% to $129000.0 in 2023, then soared by 147.29% to $319000.0 in 2024, then surged by 1337.93% to $4.6 million in 2025, then sank by 61.54% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $1.8 million in Q1 2026, $4.6 million in Q4 2025, and $266000.0 in Q3 2025.